- Top 10 U.S. Biopharma Clusters: #4. BioHealth Capital Region [Maryland / Virginia / Washington, D.C.]
BioHealth Capital Region is on the way to achieving its stated goal of growing the Maryland / Virginia / Washington, D.C. region into a top-three cluster by 2023. In addition to longtime anchors such as the NIH and FDA, and academic institutions led by The Johns Hopkins University and University of Maryland system, the life sciences have seen expanded.
- Maryland Commerce accepting applications for cybersecurity investment incentive tax credit
The Maryland Department of Commerce is now accepting applications for the Cybersecurity Investment Incentive Tax Credit, designed to attract investment in Maryland cybersecurity companies. The cybersecurity tax credit program, which originally provided a tax credit to companies receiving the investment, was revised through legislation passed during the 2018 Maryland General Assembly session.
- Sisu Global Health raises $1.2 million, launches Hemafuse sales
Sisu Global Health announced $1.2 million in funding as the Remington–based medical device startup launches sales of its first product in Africa. The convertible note round included existing investors Baltimore-based Camden Partners, Belle Michigan and AOL cofounder Steve Case’s Revolution, which invested through its Rise of the Rest Seed Fund.
- Emergent BioSolutions Joins Effort to Combat National Public Health Threat From Opioid Overdose Through Acquisition of Adapt Pharma and Its Flagship Product NARCAN® (naloxone HCl) Nasal Spray
Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to acquire Adapt Pharma and its flagship product NARCAN® (naloxone HCl) Nasal Spray, the first and only needle-free formulation of naloxone approved by the U.S. Food and Drug Administration (FDA) and Health Canada, for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression.
- CortiTech: Designing a Minimally Invasive Brain Retractor for Deep-Seated Lesions, Johns Hopkins University
The winning project was a minimally invasive brain retractor, Radiex, that provides safer surgical access to the brain for neurological operations.
- Biomedical engineering undergraduates win 2018 DEBUT Design Challenge
A team of undergraduate students studying biomedical engineering at Johns Hopkins University took home the top prize at the 2018 DEBUT Design Challenge, which recognizes promising students and their work in biomedical design and innovation.
- UNLOCKED: Meet the Baltimore Business Journal’s 2018 40 Under 40 honorees
A new generation of talent is rising in Greater Baltimore. From technology, health care and nonprofits to real estate, finance and hospitality, the region is full of young professionals who are helping to lead companies that will shape their industries for years to come. And we here at the Baltimore Business Journal had the unenviable task of selecting just 40 of these individuals to make up our 40 Under 40 class of 2018, including Alex Riehm, Director of Social Innovation Lab (SIL), and Jenny Owens from Hosts for Humanity (A venture from 2017-2018 Social Innovation Lab cohort), and Geoffrey Lynn from Avidea Technologies, a FastForward startup.
- Meet the People Empowering Baltimore Teens With Dirt Bikes, Burgers, and Yoga
For her segment of the Medicine Show, Brittany Young brought out two kids on dirt bikes to help the audience visualize the concept of her program, B-360. Young started developing the idea of using the Baltimore’s prominent dirt bike culture to teach kids about STEM in 2016. A “city schoolkid,” much like the children she works with, Young said she knows what it’s like to feel unheard and have undeveloped talent. The 29-year-old said she got in trouble a lot as a kid, until she was gifted a chemistry kit and discovered her love of science.
- Proscia Closes $8.3M Series A Round of Financing
Proscia, the pioneer in the development and advancement of digital pathology, has closed an $8.3 million round of Series A financing from a group of East and West Coast venture capital firms. The funding was led by Boston-based Flybridge Capital Partners and included Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures, and RobinHood Ventures.